Patents by Inventor Vijoleta L. B. Braach-Maksvytis

Vijoleta L. B. Braach-Maksvytis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5874316
    Abstract: The present invention provides a membrane the conductivity of which is dependent on the presence or absence of an analyte. The membrane comprises a closely packed array of self-assembling amphiphilic molecules and two ionophore components. A receptor molecule reactive with the analyte is provided on one of the ionophore components. The binding of the analyte to the receptor molecule causes a change in the relationship between the ionophore components such that the flow of ion across the membrane is prevented or allowed. The ionophore components are preferably selected from the group consisting of amphotericin B, gramicidin A monomers and combinations thereof, with gramicidin A monomers being particularly preferred. The present invention also provides a membrane including receptors directed against the Fc region of antibodies. These receptors are preferably derived from polyclonal antibodies.
    Type: Grant
    Filed: October 30, 1996
    Date of Patent: February 23, 1999
    Assignee: Australian Membrane Biotechnology Research Institute
    Inventors: Bruce A. Cornell, Vijoleta L. B. Braach-Maksvytis, Ronald J. Pace, Lionel G. King, Burkhard Raguse, Peter D. J. Osman
  • Patent number: 5443955
    Abstract: The present invention provides a membrane the conductivity of which is dependent on the presence or absence of an analyte. The membrane comprises a closely packed array of self-assembling amphiphilic molecules and two ionophore components. A receptor molecule reactive with the analyte is provided on one of the ionophore components. The binding of the analyte to the receptor molecule causes a change in the relationship between the ionophore components such that the flow of ion across the membrane is prevented or allowed. The ionophore components are preferably selected from the group consisting of amphotericin B, gramicidin A monomers and combinations thereof, with gramicidin A monomers being particularly preferred. The present invention also provides a membrane including receptors directed against the Fc region of antibodies. These receptors are preferably derived from polyclonal antibodies.
    Type: Grant
    Filed: July 3, 1991
    Date of Patent: August 22, 1995
    Assignee: Australian Membrane and Biotechnology Research Institute
    Inventors: Bruce A. Cornell, Vijoleta L. B. Braach-Maksvytis, Ronald J. Pace, Lionel G. King, Burkhard Raguse, Claire R. Baxter, Ruth M. Hall, Carol A. Morris, Peter D. J. Osman
  • Patent number: 5436170
    Abstract: The present invention provides a membrane comprising a closely packed array of self-assembly amphiphilic molecules, and is characterized in that it incorporates plurality of ion channels, and/or at least a proportion of the self-assembling molecules comprise a receptor molecule conjugated with a supporting entity. The ion channel is selected from the group consisting of peptides capable of forming helices and aggregates thereof, coronands, cryptands, podands and combinations thereof. In the amphiphilic molecules comprising a receptor molecule conjugated with a supporting entity, the receptor molecule has a receptor site and is selected from the group consisting of immunoglobulins, antibodies, antibody fragments, dyes, enzymes and lectins. The supporting entity is selected from the group consisting of a lipid head group, a hydrocarbon chain(s), a cross-linkable molecule and a membrane protein. The supporting entity is attached to the receptor molecule at an end remote from the receptor site.
    Type: Grant
    Filed: January 25, 1990
    Date of Patent: July 25, 1995
    Assignee: Commonwealth Scientific and Industrial Research Organization
    Inventors: Bruce A. Cornell, Vijoleta L. B. Braach-Maksvytis